the paris system for reporting urinary cytology
The Paris System for Reporting Urinary Cytology
$191.00 Original price was: $191.00.$4.99Current price is: $4.99. Add to cart
Sale!

The Paris System for Reporting Urinary Cytology

Original price was: $191.00.Current price is: $4.99.

-97%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

Standardizing the Urine Screen: The Paris System for Reporting Urinary Cytology

For decades, urinary cytology (the microscopic examination of cells in urine) was plagued by ambiguous, highly subjective diagnostic categories. A report of “atypical cells present” provided zero clinical utility to a urologist deciding whether to subject a patient to a painful cystoscopy. The field desperately needed a unified, clinically actionable language. The Paris System for Reporting Urinary Cytology is the definitive, fiercely pragmatic manual that revolutionized the field by creating a standardized reporting framework. This volume provides the exact blueprints required by cytopathologists to provide clear, objective diagnoses that directly guide urological management.

Mastering High-Grade Urothelial Carcinoma

The core philosophy of The Paris System is that the *only* clinically significant goal of urinary cytology is the detection of High-Grade Urothelial Carcinoma (HGUC). The authors aggressively dictate the strict, measurable morphological criteria (specifically regarding the nuclear-to-cytoplasmic ratio and hyperchromasia) required to definitively diagnose HGUC. It severely restricts the use of the term “Atypical,” reserving it only for cases with a genuinely high statistical risk of underlying malignancy.

Navigating the Diagnostic Categories and Ancillary Tests

The book provides a masterclass in objective reporting. It dictates the exact clinical pathways for assigning every urine specimen into one of the standardized Paris System categories (Negative, Atypical, Suspicious, or Positive for HGUC). It provides exhaustive guidelines on how to integrate the UroVysion FISH test into the diagnostic algorithm to clarify difficult “Atypical” cases, preventing unnecessary invasive procedures for the patient.

Frequently Asked Questions (FAQs)

Why does The Paris System ignore low-grade tumors?
Low-grade urothelial neoplasms cannot be reliably diagnosed on cytology due to their similarity to normal umbrella cells; The Paris System focuses entirely on the life-threatening high-grade lesions that cytology is excellent at detecting.

Who is the primary audience?
It is the absolute, mandatory daily manual for Cytopathologists, Urologists, General Surgical Pathologists, and Cytotechnologists.